Director Troim Adds 1.5M Shares at $4.24 in Open Market Purchase

What happened

Director Tor Olav Troim acquired 1.5 million Borr Drilling shares on October 6, 2026, at $4.24 each, a $6.36 million outlay, raising his beneficial stake to 33.5 million shares held via Drew Holdings. The purchase comes after a sharp run-up from below $2 in early 2025 to around $4.50, and follows heavy insider absence over the past year according to the master report. Troim's buy sits above the report's attractive entry of $3.75 and below its trim threshold of $5.25, signaling a level he deems undervalued despite the company's high net debt/EBITDA of 4.3x and interest coverage of just 1.5x. The master report judges Borr as a POTENTIAL SELL with conviction 4, citing execution risks from uncontracted Noble rigs, Pemex payment volatility, and rating agencies projecting leverage at 4.5-5.0x through 2026. This insider signal is a notable bullish data point but does not neutralize the balance sheet and cycle risks that underpin the cautious stance.

Implication

Investors should view Troim's purchase as a modest vote of confidence in the company's operational and asset value, but it does not alter the fundamental risk-reward that favors trimming above $5.25. The buy occurs at a price where the equity still embeds optimistic assumptions on contracting unplaced rigs and smooth Mexico cash collections. With net debt/EBITDA above 4x and interest coverage barely above 1x, the balance sheet remains fragile if jack-up dayrates soften or Pemex payments stall. Holders may use any strength toward $5.25 to reduce exposure, while potential buyers should await either a pullback toward $3.75 or tangible evidence of deleveraging and backlog quality improvement. The insider purchase alone is insufficient to warrant new buying.

Thesis delta

The master thesis rated Borr a potential sell due to high leverage and execution risk. Troim's $6.36 million insider purchase at $4.24 introduces a mild positive signal from a knowledgeable party, but it does not change the quantitative valuation or risk assessment. The thesis remains unchanged: avoid new buying; consider trimming above $5.25 and reassess if leverage trends below 3.5x or Mexico receivables normalize.